Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Salmonella biofilm protein causes autoimmune responses — Possible link with Alzheimer’s

In a study recently conducted by a team at the...

‘Living medicine’ created to treat drug-resistant infections

Researchers at the Centre for Genomic Regulation...

By changing their shape, some bacteria can grow more resilient to antibiotics

ScienceDaily recently reported on new research...

Antibiotics significantly overprescribed during early months of pandemic, study suggests

According to a study recently shared by Becker’s...

Engineered bacteria could help protect ‘good’ gut microbes from antibiotics

Engineered bacteria could help protect ‘good’...

COVID-19 cited in significant increase in healthcare-associated infections in 2020

According to ScienceDaily, a CDC analysis of...

Distribuidor exclusivo.

0